Literature DB >> 18374690

The risk of infection after nasal colonization with Staphylococcus aureus.

Nasia Safdar1, Elisa A Bradley.   

Abstract

PURPOSE: Nasal, axillary, or inguinal colonization with Staphylococcus aureus generally precedes invasive infection. Some studies have found that colonization with methicillin-resistant S. aureus (MRSA) poses a greater risk of clinical infection than colonization with methicillin-susceptible S. aureus (MSSA). However, the magnitude of risk is unclear.
METHODS: We undertook a systematic review to provide an overall estimate of the risk of infection following colonization with MRSA compared with colonization by MSSA. Ten observational studies, with a total of 1170 patients, were identified that provided data on both MSSA and MRSA colonization and infection. A random-effects model was used to obtain pooled estimates of the odds ratio and 95% confidence interval.
RESULTS: Overall, colonization by MRSA was associated with a 4-fold increase in the risk of infection (odds ratio 4.08, 95% confidence interval, 2.10-7.44). Studies differed in the choice of patient population, severity of illness, and frequency of sampling to detect colonization.
CONCLUSION: Further research is needed to identify effective methods for sustained eradication of MRSA carriage to reduce the high risk of subsequent infection.

Entities:  

Mesh:

Year:  2008        PMID: 18374690     DOI: 10.1016/j.amjmed.2007.07.034

Source DB:  PubMed          Journal:  Am J Med        ISSN: 0002-9343            Impact factor:   4.965


  95 in total

1.  Prevalence and risk factors for MRSA nasal colonization among persons experiencing homelessness in Boston, MA.

Authors:  Jessica H Leibler; Casey León; Lena J P Cardoso; Jennifer C Morris; Nancy S Miller; Daniel D Nguyen; Jessie M Gaeta
Journal:  J Med Microbiol       Date:  2017-08       Impact factor: 2.472

2.  Detection of mobile-genetic-element variation between colonizing and infecting hospital-associated methicillin-resistant Staphylococcus aureus isolates.

Authors:  Alex J McCarthy; Aodhan S Breathnach; Jodi A Lindsay
Journal:  J Clin Microbiol       Date:  2011-12-14       Impact factor: 5.948

3.  Morphometric measurements of the anterior skull base for endoscopic transoral and transnasal approaches.

Authors:  Bradley C Lega; Daniel R Kramer; Jason G Newman; John Y K Lee
Journal:  Skull Base       Date:  2011-01

4.  Comparison of flocked and rayon swabs for detection of nasal carriage of Staphylococcus aureus among pathology staff members.

Authors:  Sabine De Silva; Gillian Wood; Tricia Quek; Christine Parrott; Catherine M Bennett
Journal:  J Clin Microbiol       Date:  2010-05-26       Impact factor: 5.948

Review 5.  MRSA: treating people with infection.

Authors:  Nikolas Rae; Anna Jarchow-MacDonald; Dilip Nathwani; Charis Ann Marwick
Journal:  BMJ Clin Evid       Date:  2016-02-16

6.  Comparison of chromogenic media to BD GeneOhm methicillin-resistant Staphylococcus aureus (MRSA) PCR for detection of MRSA in nasal swabs.

Authors:  Larry J Bischof; Linda Lapsley; Karen Fontecchio; Dollie Jacosalem; Carol Young; Rosemary Hankerd; Duane W Newton
Journal:  J Clin Microbiol       Date:  2009-05-13       Impact factor: 5.948

7.  Methicillin-resistant Staphylococcus aureus in patients with congenital heart disease in the pediatric intensive care unit.

Authors:  Saran Wells; Tiffany Anderson; Alexander Tiemieier; Joanna Wrobel; Nizar Maraqa; Carmen Smotherman; Sarah Wheeler; Christine Bailey; Dale Kraemer; Mobeen H Rathore
Journal:  World J Pediatr Congenit Heart Surg       Date:  2013-10

8.  A prevalence screen of MRSA nasal colonisation amongst UK doctors in a non-clinical environment.

Authors:  R R W Brady; C McDermott; C Graham; E M Harrison; G Eunson; A P Fraise; M G Dunlop; A P Gibb
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2009-02-24       Impact factor: 3.267

9.  Long-term risk for readmission, methicillin-resistant Staphylococcus aureus (MRSA) infection, and death among MRSA-colonized veterans.

Authors:  Nestor M Quezada Joaquin; Daniel J Diekema; Eli N Perencevich; George Bailey; Patricia L Winokur; Marin L Schweizer
Journal:  Antimicrob Agents Chemother       Date:  2012-12-17       Impact factor: 5.191

10.  Mupirocin/chlorexidine to prevent methicillin-resistant Staphylococcus aureus infections: post hoc analysis of a placebo-controlled, randomized trial using mupirocin/chlorhexidine and polymyxin/tobramycin for the prevention of acquired infections in intubated patients.

Authors:  C Camus; V Sebille; A Legras; B Garo; A Renault; P Le Corre; P-Y Donnio; A Gacouin; D Perrotin; Y Le Tulzo; E Bellissant
Journal:  Infection       Date:  2014-01-25       Impact factor: 3.553

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.